OFFICIAL PUBLICATION OF

by its subsidiary APPco

Ozempic shortage to continue in 2025

AJP Staff 18/12/2024

Diabetes medication to remain in short supply throughout 2025, manufacturer warns Efforts to boost the production of Ozempic (semaglutide) are not expected to alleviate shortages of the medication in the next 12 months. Novo Nordisk has advised the Therapeutic Goods Administration (TGA) and the Ozempic Medicine Shortage Action Group that supply will continue to be

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Patients back scope expansion

“By and large, consumers are frustrated that pharmacists are prevented from prescribing medicines for common, non-complex conditions such as diabetes,…

Anthony Zirilli

Patients back scope expansion

Exactly. I think for qualitative research, a sample size of 100 is relatively large and, to a certain extent and…

Benjamyn Sung

Forged scripts warning

Never ends my friend

Jay cutler

Patients back scope expansion

Sample size of 100…well that’s it folks case closed in this one. Also, why is it important what consumers want?…

John Smith

Ozempic shortage to continue in 2025

Previous Patients back scope expansion

Next Red eyes: summer eye care tips

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Patients back scope expansion

Next Red eyes: summer eye care tips

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.